Do's And Don’ts: GMP Risk Assessments For Cross Contamination Between Products.

Add bookmark
Chanice Henry
Chanice Henry
02/16/2016

Cross contamination within drug production is of prime focus, with potential consequences for patients and workers. (1) As mentioned by Fierce Markets Custom Publishing, one tactic to maintain costs with manufacturing production lines is to process them in parallel. However, especially when the lines process conflicting active pharmaceutical ingredients, there is an increased chance of cross contamination between lines.  This could be airborne, via worker’s garments or by contaminated equip...
To continue reading this story get free access

RECOMMENDED